What’s New in Washington: What Congress Is Doing About Drug Pricing and Surprise Medical Billing
Subscribe to OnAir with Akin Gump via iTunes, SoundCloud YouTube, Spotify and Google Play.
In this episode, Akin Gump health care and life sciences senior counsel Taylor Jones and public law and policy senior policy advisor Julie Nolan discuss draft legislation currently on Capitol Hill focusing on drug pricing and surprise medical billing.
Among the topics covered:
- What’s driving legislation?
- Which draft bills have the most support?
- What role does the international pharmaceutical market play?
- What impact will impeachment proceedings have?
Learn more about these practice areas on akingump.com.
Attachments
© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.